Showing results (981-990 of 1,073) with videos related to
Sort By:
Pageof 108
Bioorganic & Medicinal Chemistry Letters|February 13, 2009
N-(3-fluoro-4-(2-arylthieno[3,2-b]pyridin-7-yloxy)phenyl)-2-oxo-3-phenylimidazolidine-1-carboxamides: a novel series of dual c-Met/VEGFR2 receptor tyrosine kinase inhibitorsStéphane Raeppel, Stephen Claridge, Oscar Saavedra, et al.Bioorganic & Medicinal Chemistry Letters|October 27, 2009
N-(4-(6,7-Disubstituted-quinolin-4-yloxy)-3-fluorophenyl)-2-oxo-3-phenylimidazolidine-1-carboxamides: a novel series of dual c-Met/VEGFR2 receptor tyrosine kinase inhibitorsMichael Mannion, Stéphane Raeppel, Stephen Claridge, et al.Cancer Communications (London, England)|April 10, 2026
Proliferation and Apoptosis Adaptor Protein 15 (PEA15), a Potential Oncogenic Regulator of VHL and HIF1A Identified through Proteomic Analysis in Hepatocellular CarcinomaYun Seong Jeong, Ji-Hyun Shin, Soo Mi Kim, et al.Critical Reviews in Toxicology|May 20, 2011
A proposed framework for assessing risk from less-than-lifetime exposures to carcinogensSusan P Felter, Rory B Conolly, Joel P Bercu, et al.Nature Materials|August 4, 2014
A time-dependent order parameter for ultrafast photoinduced phase transitionsP Beaud, A Caviezel, S O Mariager, et al.Nature|June 10, 2016
Image-based detection and targeting of therapy resistance in pancreatic adenocarcinomaRaymond G Fox, Nikki K Lytle, Dawn V Jaquish, et al.Bioorganic & Medicinal Chemistry Letters|April 25, 2008
Discovery of a novel and potent series of thieno[3,2-b]pyridine-based inhibitors of c-Met and VEGFR2 tyrosine kinasesStephen Claridge, Franck Raeppel, Marie-Claude Granger, et al.Nature Computational Science|January 4, 2024
Unconstrained generation of synthetic antibody-antigen structures to guide machine learning methodology for antibody specificity predictionPhilippe A Robert, Rahmad Akbar, Robert Frank, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 2014
Randomized comparison of gemcitabine, dexamethasone, and cisplatin versus dexamethasone, cytarabine, and cisplatin chemotherapy before autologous stem-cell transplantation for relapsed and refractory aggressive lymphomas: NCIC-CTG LY.12Michael Crump, John Kuruvilla, Stephen Couban, et al.Bioorganic & Medicinal Chemistry Letters|November 6, 2007
N-(2-Amino-phenyl)-4-(heteroarylmethyl)-benzamides as new histone deacetylase inhibitorsArkadii Vaisburg, Isabelle Paquin, Naomy Bernstein, et al.Pageof 108